Effect | None |
Trial Design | Randomized trial |
Trial Length | n/a |
Number of Subjects | 30 |
Sex | Both Genders |
Age Range | 45-64 |
6 weeks of 400mg Sulbutiamine was unable to influence symptoms and signs of diabetic neuropathy although it did significantly benefit electrophysical readings; no influence was noted in blood glucose or HbA1c